Sort
48,018 grants matching “immunotherapy”
The Ohio State University as a Lead Academic Organization (LAO) for the Experimental Therapeutics Clinical Trials Network
$5,479,018William E. Carson · Ohio State University · UM1 · FY2020 · CA
Mayo Comprehensive Cancer Center Grant
$5,470,597Robert B. Diasio · Mayo Clinic Rochester · P30 · FY2012 · CA
SURGERY, IMMUNOLOGY AND IMMUNOTHERAPY OF HUMAN CANCER
$5,456,450John Wayne Cancer Institute · P01 · FY2005 · CA
Delaney AIDS Research Enterprise to Cure HIV
$5,455,521Steven Grant Deeks · University Of California, San Francisco · UM1 · FY2024 · AI
Delaney AIDS Research Enterprise to Cure HIV
$5,452,430Steven Grant Deeks · University Of California, San Francisco · UM1 · FY2023 · AI
UW Comprehensive Cancer Center Support
$5,450,317University Of Wisconsin Madison · P30 · FY2004 · CA
Delaney AIDS Research Enterprise to Cure HIV
$5,448,894Steven Grant Deeks · University Of California, San Francisco · UM1 · FY2022 · AI
Adult Leukemia Research Center
$5,431,018Frederick R Appelbaum · Fred Hutchinson Cancer Research Center · P01 · FY2011 · CA
Vascular-immune mechanisms of cerebral amyloid angiopathy and Alzheimer's pathology
$5,423,836Andrew Chris Yang · J. David Gladstone Institutes · RF1 · FY2024 · NS
URCC NCORP Research Base
$5,423,270Karen M Mustian · University Of Rochester · UG1 · FY2020 · CA
HIV VACCINE DESIGN AND DEVELOPMENT TEAMS (HVD
$5,415,284Charles Nicolette · Argos Therapeutics, Inc. · N01 · FY2013 · AI
Neuropathogenesis of Retroviral Infections
$5,346,668Avindra Nath · National Institute Of Neurological Disorders And Stroke · ZIA · FY2025 · NS
Mayo Comprehensive Cancer Center Grant
$5,345,058Robert B. Diasio · Mayo Clinic Rochester · P30 · FY2013 · CA
Gene therapy of cancer
$5,342,262Steven Rosenberg · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Adoptive Cell Transfer Immunotherapy of Cancer
$5,342,262Steven Rosenberg · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
DCTD Biopharmaceutical Development
$5,333,006David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2014 · CA
Cancer Center Support Grant
$5,317,547Michael A Teitell · University Of California Los Angeles · P30 · FY2025 · CA
FDA approved IND 29644: Multicenter Phase 1 Trial to Evaluate Safety and Immunogenicity of Preventive Tau Vaccine, AV-1980R/A, in cognitively unimpaired preclinical AD participants.
$5,308,961Michael G Agadjanyan · Institute For Molecular Medicine · R01 · FY2025 · AG
UW Comprehensive Cancer Center Support
$5,307,818University Of Wisconsin Madison · P30 · FY2003 · CA
Adult Leukemia Research Center
$5,273,382Frederick R Appelbaum · Fred Hutchinson Cancer Research Center · P01 · FY2009 · CA
Cancer Center Support Grant
$5,266,903Michael A Teitell · University Of California Los Angeles · P30 · FY2023 · CA
Cancer Center Support Grant
$5,266,903Michael A Teitell · University Of California Los Angeles · P30 · FY2021 · CA
Cancer Center Support Grant
$5,266,903Michael A Teitell · University Of California Los Angeles · P30 · FY2024 · CA
Cancer Center Support Grant
$5,266,903Michael A Teitell · University Of California Los Angeles · P30 · FY2022 · CA
Cancer Center Support Grant
$5,266,903Michael A Teitell · University Of California Los Angeles · P30 · FY2020 · CA